SecBot SecBot
144 ·Filed Nov 2, 2026

PCVX

Vaxcyte, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed14d 5h ago SEC0001969223-26-001117
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine insider intent-to-sell notice for a small position. Monitor for any acceleration of insider selling patterns or larger filings that could signal changing sentiment among management.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$60.81
T+0 close · Nov 2, 2026 · via day close
Latest settled
+9.13%
T+5 · $66.36 · next T+20 in 15d
Vs SPY
+9.71%
α at T+5
Latest observation
+4.75%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $60.81entry
  2. T+1 · 13d ago +8.01%α +6.36% · $65.68
  3. T+5 · 7d ago +9.13%α +9.71% · $66.36
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Jim Wassil, an officer of Vaxcyte, filed a Form 144 notice of intent to sell 2,250 shares of common stock, with an approximate market value of $139,230. The shares are to be sold through UBS Financial Services on or after November 2, 2026, following the exercise of stock options. This is a relatively small sale relative to the company's $9.9B market cap and the officer's recent selling history, and is consistent with routine insider transactions for tax or diversification purposes.

Key Facts

  • Jim Wassil, an officer of Vaxcyte, filed Form 144 to sell 2,250 shares of common stock.
  • The proposed sale value is approximately $139,230 based on the filing date.
  • The shares were acquired via exercise of stock options on November 2, 2026.
  • The sale is to be executed through UBS Financial Services Inc.
  • The filing shows Wassil has sold shares in multiple transactions from August to October 2026, totaling over $2.2M in prior sales.
  • The proposed sale represents about 0.0014% of Vaxcyte's $9.9B market cap.

Financial Impact

Proposed sale of 2,250 shares valued at approximately $139,230, a de minimis amount relative to the company's $9.9B market cap.

dilution

Risk Factors

  • Form 144 is only an intent to sell; the actual sale may not occur.
  • The officer has a history of periodic option exercises and sales, so this is not an unusual pattern.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
88% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001969223-26-001117
Document: 0001969223-26-001117-index.html0001969223-26-001117
Document: 0001969223-26-001117.txt0001969223-26-001117

Track record

29 reports on PCVX

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +10.87% at T+5 after the Oct 8, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $62.40 Now $63.37 +1.55% settles Dec 15
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $64.69 Now $63.37 −2.04% settles Dec 11
  3. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $63.89 Now $63.37 −0.81% settles Dec 7
  4. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $63.89 Now $63.37 −0.81% settles Dec 7
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $61.92 Now $63.37 +2.34% settles Dec 4
  6. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $61.92 Now $63.37 +2.34% settles Dec 4
  7. Nov 2, 202614d ago 144 Neutral 2/10 Viewing Entry $60.81 Now $63.37 +4.21% settles Dec 2
  8. Nov 2, 202614d ago 144 Neutral 2/10 Entry $60.81 Now $63.37 +4.21% settles Dec 2
  9. Oct 9, 20265w ago 8-K Bearish 6/10 Entry $70.65 to $67.53 Now $63.37 +10.30% ▲ +4.42% +1.15% vs SPY
  10. Oct 8, 20265w ago 424B5 Bearish 6/10 Entry $71.38 to $63.89 Now $63.37 +11.22% ▲ +10.49% +4.93% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens Wed (11h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026